ViCentra scales manufacturing, triples capacity to 17,000+Users
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to […]
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to […]
Marketing executive brings 20+ years of global diabetes experience to support European scale-up and next-generation Kaleido launch readiness Utrecht, the
Karen Baxter, former VP & GM at Dexcom with deep expertise in diabetes device commercialization across Europe, joins as SVP
Led by new investor Innovation Industries, with matching contributions from existing investors, Partners in Equity and Invest-NL, the $85M round
We’re excited to share that we’re preparing for the pre-launch of DBLG2, a new Hybrid Closed Loop app developed by
Kaleido patch pump system with Diabeloop’s DBLG2 algorithm and Dexcom G7 CGM to launch in Germany and the Netherlands, bringing
Utrecht, The Netherlands – February 26, 2025 ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest, and
Announcing your favourite sport or physical activity is now even easier using Kaleido & DBLG1. It’s so important to us
Utrecht, Netherlands — 16th October 2024 ViCentra, an innovative leader in Diabetes technology, is proud to announce that its Kaleido
ViCentra has been featured in the MedTech Strategist Magazine focused on the medtech industry. ViCentra, founded in 2013 and based